HIF1A and breast carcinoma: On the basis of the foregoing, this pathway could be the reason why HIF-1α expression incremented in this study due to the increase in oxidative stress status in breast cancer patients who received neoadjuvant chemotherapy treatment, as described in previous investigations of our group [43].